These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 4119497

  • 21. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
    Fujimoto S, Chen CH, Sabbadini E, Sehon AH.
    J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
    [No Abstract] [Full Text] [Related]

  • 22. Suppression and enhancement of allografted tumour.
    Yutoku M, Seno H, Matsuoka Y, Kitagawa M.
    Immunology; 1974 Mar; 26(3):623-37. PubMed ID: 4854531
    [Abstract] [Full Text] [Related]

  • 23. Symposium. Myeloma. b. Immunoglobulin changes in mice with experimental plasmacytoma.
    Hashimoto N.
    Nihon Ketsueki Gakkai Zasshi; 1970 Feb; 33(1):16-27. PubMed ID: 4098551
    [No Abstract] [Full Text] [Related]

  • 24. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E, Weiland F.
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract] [Full Text] [Related]

  • 25. In vitro and in vivo alterations of long-term murine plasmacytoma cultures.
    Sorenson GD, Pettengill OS.
    Arch Intern Med; 1975 Jan; 135(1):114-8. PubMed ID: 1111460
    [Abstract] [Full Text] [Related]

  • 26. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
    Freedman LR, Cerottini JC, Brunner KT.
    J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
    [No Abstract] [Full Text] [Related]

  • 27. Evaluation of organ specificity in renal allograft enhancement with F(ab') 2 fragments.
    Shaipanich T, Wren S, von Haefen U, Koppenheffer T, Busch G, Wilson RE.
    Transplant Proc; 1973 Mar; 5(1):581-3. PubMed ID: 4572116
    [No Abstract] [Full Text] [Related]

  • 28. [Demonstration of paraproteins using simple gel diffusion technics].
    Keitel W, Gutschmidt HJ.
    Acta Biol Med Ger; 1967 Mar; 19(6):1037-46. PubMed ID: 4173823
    [No Abstract] [Full Text] [Related]

  • 29. Preparation and properties of rabbit anti-mouse plasmacyte serum purified by in vivo absorption: further evidence for a new antigenic determinant on plasmacytes.
    Yutoku M, Grossberg AL, Pressman D.
    J Immunol; 1974 Mar; 112(3):911-8. PubMed ID: 4130115
    [No Abstract] [Full Text] [Related]

  • 30. Antigenic studies of J chain.
    Meinke GC, Spiegelberg HL.
    J Immunol; 1974 Apr; 112(4):1401-6. PubMed ID: 4205528
    [No Abstract] [Full Text] [Related]

  • 31. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M.
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract] [Full Text] [Related]

  • 32. [Quantitative serum protein determinations in paraproteinemic hemoblastoses].
    Rentsch I.
    Arch Klin Med; 1969 May; 216(5):471-9. PubMed ID: 4190065
    [No Abstract] [Full Text] [Related]

  • 33. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H, Fukuzawa M, Yoshioka T, Nakajima H, Hamaoka T.
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [Abstract] [Full Text] [Related]

  • 34. Studies on liver cancer. II. Production of alpha-fetoprotein by experimental hepatoma and its characterization.
    Koda T, Ishigami S, Tanabe S.
    Biken J; 1973 Dec; 16(4):129-39. PubMed ID: 4132938
    [No Abstract] [Full Text] [Related]

  • 35. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J, Ziegler HW, Kölsch E.
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [Abstract] [Full Text] [Related]

  • 36. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.
    Hengst JC, Mokyr MB, Dray S.
    Cancer Res; 1980 Jul; 40(7):2135-41. PubMed ID: 6446379
    [No Abstract] [Full Text] [Related]

  • 37. Tumor-bound immunoglobulins: their possible role in circumventing antitumor immunity.
    Witz IP, Levy HJ, Keisari Y, Izsak FC.
    Johns Hopkins Med J Suppl; 1974 Jul; 3():289-300. PubMed ID: 4214276
    [No Abstract] [Full Text] [Related]

  • 38. [Mouse rosette forming cells in transplantation immunity].
    Brondz BD, Eliseeva LS, Kotomina IF, Egorova SG.
    Tsitologiia; 1974 Jan; 16(1):74-81. PubMed ID: 4142816
    [No Abstract] [Full Text] [Related]

  • 39. [Immunoglobulin secreting tumors in the LOU-Wsl rat: Study of 200 immunocytomas].
    Bazin H.
    Ann Immunol (Paris); 1974 Jan; 125C(1-2):277-9. PubMed ID: 4460871
    [No Abstract] [Full Text] [Related]

  • 40. [Immunologic aspects of murine allogeneic tumor growth (author's transl)].
    Braun M, Saal F, Pasqualini CD.
    Sangre (Barc); 1974 Jan; 19(2):153-7. PubMed ID: 4409784
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.